Retevmo：Retevmo

Retevmo

這是什麼藥物？SELPERCATINIB可治療特定類型的癌症。其作用方式是阻斷造成癌細胞的蛋白，使其無法生長與增殖。有助於減緩或停止癌細胞的擴散。。其他文章還包含有：「FDAapprovesselpercatinibforRETfusion」、「HowRetevmoWorks」、「RETEVMO®(selpercatinib)capsules」、「Retevmo®(selpercatinib)」、「Selpercatinib(Retevmo)」、「禮來首款RET抑制劑Retevmo轉為正式批准FDA再批用於...」、「第一個RET抑制劑，FDA核准禮來...

查看更多離開網站

pralsetinib仿單 Selpercatinib

Provide From Google

FDA approves selpercatinib for RET fusion

https://www.fda.gov

The Food and Drug Administration granted traditional approval to selpercatinib (Retevmo, Eli Lilly and Company) for adult and pediatric patients 2 years of age ...

Provide From Google

How Retevmo Works

https://retevmo.lilly.com

Retevmo is a prescription oral therapy that was designed to block the primary driver of tumor growth in RET-positive advanced non-small cell lung cancer (NSCLC ...

Provide From Google

RETEVMO® (selpercatinib) capsules

https://www.accessdata.fda.gov

RETEVMO is indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic thyroid cancer with a RET gene ...

Provide From Google

Retevmo® (selpercatinib)

https://retevmo.lilly.com

Retevmo (selpercatinib) is an oral therapy that can be taken at home and is for people with certain advanced cancers that test positive for RET.

Provide From Google

Selpercatinib (Retevmo)

https://www.ncbi.nlm.nih.gov

Evidence from a clinical trial demonstrated that people with metastatic RET fusion-positive NSCLC treated with Retevmo experienced tumour shrinkage or the ...

Provide From Google